Cataract incidence after total-body irradiation

International Journal of Radiation Oncology Biology Physics

Volumn 46, Issue 1, 2000, Pages 131-135

  Zierhut, Dietmar ^a   Lohr, Frank ^a   Schraube, Peter ^a   Huber, Peter ^a   Wenz, Frederik ^a   Haas, Rainer ^a   Fehrentz, Dieter ^a   Flentje, Michael ^a   Hunstein, Werner ^a   Wannenmacher, Michael ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Bone marrow transplant; Cataract; Radiotherapy; Total body irradiation (TBI); Toxicity

Indexed keywords

CYCLOPHOSPHAMIDE;

ACUTE LEUKEMIA; ADOLESCENT; ADULT; ARTICLE; AUTOLOGOUS BONE MARROW TRANSPLANTATION; BLOOD DISEASE; CATARACT; FEMALE; FOLLOW UP; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MULTIPLE MYELOMA; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL; WHOLE BODY RADIATION;

ADULT; BONE MARROW TRANSPLANTATION; CATARACT; COMBINED MODALITY THERAPY; FEMALE; FOLLOW-UP STUDIES; HEMATOLOGIC NEOPLASMS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; INCIDENCE; MALE; RADIATION INJURIES; RETROSPECTIVE STUDIES; WHOLE-BODY IRRADIATION;

EID: 0033957690     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0360-3016(99)00354-5     Document Type: Article

References (34)

1. Cassileth P.A., Andersen J.W., Bennett J.M., et al. Escalating the intensity of postremission therapy improves the outcome in acute myeloid leukemia The ECOG experience . Leukemia. 6:1992;116-119.
2. Kim T.H., McGlave P.B., Ramsay N., et al. Comparison of two total body irradiation regimens in allogeneic bone marrow transplantation for acute non-lymphoblastic leukemia in first remission. Int J Radiat Biol Oncol Phys. 19:1990;889-897.
3. Attal M., Harousseau J.-L., Stoppa A.-M., et al. A prospective randomized trial of autologous bone marrow transplantation and chemotherapy in multiple myeloma. N Engl J Med. 335:1996;91-97.
4. Philip T., Guglielmi C., Hagenbeek A., et al. Autologous bone marrow transplantation as compared with salvage chemotherapy in relapses of chemotherapy-sensitive non-Hodgkin's lymphoma. N Engl J Med. 333:1995;1540-1545.
5. Dusenbery K.E., Daniels K.A., McClure J.S., et al. Randomized comparison of cyclophosphamide-total body irradiation versus busulfan-cyclophosphamide conditioning in autologous bone marrow transplantation for acute myeloid leukemia. Int J Radiat Oncol Biol Phys. 31:1995;119-128.
6. MacFaul P.A., Bedford M.A. Ocular complications after therapeutic irradiation. Br J Ophthalmol. 54:1970;237-247.
7. Sibley G.S., Mundt A.J., Goldman S., et al. Patterns of failure following total body irradiation and bone marrow transplantation with or without a radiotherapy boost for advanced neuroblastoma. Int J Radiat Oncol Biol Phys. 32:1995;1127-1135.
8. Deeg H.J., Flournoy N., Sullivan K.M., et al. Cataracts after total body irradiation and marrow transplantation A sparing effect of dose fractionation . Int J Radiat Oncol Biol Phys. 10:1984;957-964.
9. Chou R.H., Wong G.B., Kramer J.H., et al. Toxicities of total-body irradiation for pediatric bone marrow transplantation. Int J Radiat Oncol Biol Phys. 34:1996;843-851.
10. Fehrentz D., Körbling M., Weischedel U. Hyperfractionated total body irradiation as part of autologous bone marrow transplantation. Strahlenther Onkol. 162:1986;246-247.
11. Keilholz U., Körbling M., Fehrentz D., et al. Long-term endocrine toxicity of myeloablative treatment followed by autologous bone marrow/blood derived stem cell transplantation in patients with malignant lymphohematopoietic disorders. Cancer. 64:1989;641-645.
12. Körbling M., Fliedner T.M., Holle R., et al. Autologous blood stem cell transplantation (ABSCT) versus purged bone marrow transplantation (pABMT) in standard risk AML Influence of source and cell composition of the autograft on hemopoietic reconstitution and disease-free survival . Bone Marrow Transplant. 7:1991;343-349.
13. Kaplan E.L., Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc. 53:1958;457-481.
14. Livesey S.J., Holmes J.A., Whittaker J.A. Ocular complications of bone marrow transplantation. Eye. 3:1989;271-276.
15. Ozsahin M., Belkacemi Y., Pene F., et al. Total-body irradiation and cataract incidence A randomized comparison of two instantaneous dose rates . Int J Radiat Oncol Biol Phys. 28:1993;343-347.
16. Calissendorff B.M., Lonnqvist B., Azazi M. Cataract development in adult bone marrow transplant recipients. Acta Ophthalmol Scand. 73:1995;152-154.
17. Hamon M.D., Gale R.F., Macdonald I.D., et al. Incidence of cataracts after single fraction total body irradiation The role of steroids and graft versus host disease . Bone Marrow Transplant. 12:1993;233-236.
18. Henk J.M., Whitelock A.F., Warrington A.P., et al. Radiation dose to the lens and cataract formation. Int J Radiat Oncol Biol Phys. 25:1993;815-820.
19. Merriam G.R. Jr, Focht E.F. A clinical study of radiation cataracts and the relationship to dose. Am J Roentgenol. 77:1957;759-785.
20. Latz D., Schraube P., Wannenmacher M. Acute tolerance of hyperfractionated accelerated total body irradiation. Strahlenther Onkol. 172:1996;685-689.
21. Lohr F., Wenz F., Schraube P., et al. Lethal pulmonary toxicity after autologous bone marrow transplantation/peripheral blood stem cell transplantation for hematological malignancies. Radiother Oncol. 48:1998;45-51.
22. Wenz F., Steinvorth S., Lohr F., et al. Acute central nervous system (CNS) toxicity of total body irradiation (TBI) measured using neuropsychological testing of attention functions. Int J Radiat Oncol Biol Phys. 44:1999;891-894.
23. Benyunes M.C., Sullivan K.M., Deeg H.J., et al. Cataracts after bone marrow transplantation Long-term follow-up of adults treated with fractionated total body irradiation . Int J Radiat Oncol Biol Phys. 32:1995;661-670.
24. Barrett A., Nicholls J., Gibson B. Late effects of total body irradiation. Radiother Oncol. 9:1987;131-135.
25. Bray L.C., Carey P.J., Proctor S.J., et al. Ocular complications of bone marrow transplantation. Br J Ophthalmol. 75:1991;611-614.
26. Belkacémi Y., Pène F., Touboul E., et al. Total-body irradiation before bone marrow transplantation for acute leukemia in first or second complete remission. Results and prognostic factors in 326 consecutive patients. Strahlenther Onkol. 174:1998;92-104.
27. Belkacémi Y., Ozsahin M., Pène F., et al. Cataractogenesis after total body irradiation. Int J Radiat Oncol Biol Phys. 35:1996;53-60.
28. Belkacémi Y., Labopin M., Vernant J.-P., et al. Cataracts after total body irradiation and bone marrow transplantation in patients with acute leukemia in complete remission. A study of the European group for blood and marrow transplantation. Int J Radiat Oncol Biol Phys. 41:1998;659-668.
29. Urban R.C. Jr, Cotlier E. Corticosteroid-induced cataracts. Surv Ophthalmol. 31:1986;102-110.
30. Ozsahin M., Pène F., Touboul E., et al. Total-body irradiation before bone marrow transplantation. Cancer. 69:1992;2853-2865.
31. Fife K., Milan S., Westbrook K., et al. Risk factors for requiring cataract surgery following total body irradiation. Radiother Oncol. 33:1994;93-98.
32. Vizel M., Oster M.W. Ocular side effects of cancer chemotherapy. Cancer. 49:1982;1999-2002.
33. Kende G., Sirkin S.R., Thomas P.R.M., et al. Blurring of vision - a previously undescribed complication of cyclophosphamide therapy. Cancer. 44:1979;69-71.
34. Leske M.C., Sperduto R.D. The epidemiology of senile cataracts A review . Am J Epidemiol. 118:1983;152-165.